Perceptions About Nasal Glucagon in Young Adults and Caregivers
Our mission at the T1D Exchange is to improve the lives of people with type 1 diabetes (T1D). A large…
ADCES 2023: Improving Patient Care & Outcomes in Type 1 Diabetes
This year’s Association of Diabetes Care & Education Specialists (ADCES) conference was held in Houston, TX on August 4 –…
The Journey to a Potential Islet Cell Replacement Therapy for Type 1 Diabetes
When Doug Melton, Ph.D., began his mission to develop an insulin-producing beta cell from a stem cell, he predicted it…
The Impact of Using a CGM Within Six Months of Your T1D Diagnosis
At this year’s American Diabetes Association 83rd Scientific Sessions, T1D Exchange presented three oral presentations, two panel discussions, and fifteen…
Empowering People with Diabetes in the LGBTQ+ Community with Inclusive Care
Research from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) emphasizes the crucial need to examine how healthcare systems cater to…
Juneteenth: A Critical Reminder that Black People with Diabetes Deserve Better Healthcare
Frankly, what we know about the healthcare provided to people of color with type 1 diabetes (T1D) is heartbreaking and…
How Increasing Temperatures, Pollution & Natural Disasters Affect People with Diabetes Across the Globe
“Climate change is arguably one of the biggest health threats today and is estimated to cause approximately 250,000 additional deaths…
Fear of Hypoglycemia: New Tool Helps Docs Identify “FoH” in People with Diabetes
Hypoglycemia (low blood glucose) can be terrifying. Even a relatively mild hypo can be so uncomfortable, nerve-wracking, stressful, and scary…
Improving Diabetes Healthcare: Creating Space for Providers to Learn & Share
When healthcare providers from different clinics share and learn from each other, patients win. While we continue to see the…
Promising Treatment for Recently Diagnosed Type 1 Diabetes Receives JDRF Funding
Diamyd Medical and JDRF recently announced a four-year research and development collaboration focused largely on the Phase 3 trial of…
